Expenditure on medical devices in Italy: report published by the Ministry of Health

01

Mar 2018

The analysis showed that the expenditure on medical devices (i.e., medical devices, active implantable medical devices, and in vitro diagnostic devices) in 2016 increased of 1.4% compared to 2015. The highest figure was registered for implantable medical devices (+3.7%).

The Regions with the highest volumes were Lombardia (EUR 599,008,730), Veneto (EUR 420,105,473), Emilia Romagna (EUR 394,547,901), and Toscana (EUR 378,124,997).

The top 4 classes of medical devices, accounting for 51.6% of the total expenditure in 2016, were the following:

  • Prosthetic implantable devices and osteosynthesis products: 20.8% of the total (+4.6% compared to 2015). Within this class, 85.6% were orthopaedic prostheses (49.4%) and vascular and cardiac prostheses (36.2%).
  • Devices for the cardiocirculatory apparatus: 12.1% of the total (+5.8% compared to 2015). Within this class, 80% were arterio-venous devices (54.2%), arrhythmology devices (13.2%), and guide-wires (12%).
  • Active implantable devices: 9.8% of the total (+5% compared to 2015). Within this class, 86.6% were devices for the cardiac functions.
  • Devices for administration and collection: 8.9% of the total (+9.4% compared to 2015). Within this class, 69% were conduits and tubes (30.4%), needles (22.6%), and liquid collection devices (15.9%).

See the report in Italian here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

25

Nov 2022

In November 2022, Swedish Medical Technologies Product (MTP) Council issued a policy of proven experience for medical technology, which complies profession's assessment of how appropriate medical technology is in specific conditions. The policy provides some examples of how the MTP Council acquires knowledge of proven experience and its impact on the MTP Council's recommendations.

Read more

23

Nov 2022

The HTA body of the Tuscany Regional Healthcare issues three types of documents: full HTA reports, rapid HTA reports, and motivational forms. With regional decree 21738 of November 4, 2022, Tuscany Regional Healthcare has published assessments of three medical devices in the orthopedics, surgical procedures, and peripheral vascular areas.

Read more

21

Nov 2022

In November 2022, NHS England defined a deadline for applications to the High Cost Device List (HCDL) changes to be implemented in the 2024/25 National Tariff Payment System. The completed application form should be submitted via email by May 31, 2023.

Read more

10

Nov 2022

The French National Authority for Health released new recommendations about add-on reimbursement of medical devices and medical aids from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies in October 2022. Fourteen recommendations were published in relation to the registration, modification of registration conditions, and renewal of registration for devices in the List of reimbursable products and services. Opinions concern cardiovascular, neurovascular, orthopedic, and ENT devices, as well as medical aids.

Read more

06

Oct 2022

The French National Authority for Health released new recommendations about add-on reimbursement of medical devices and medical aids from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies in September 2022. Thirty-eight recommendations were published in relation to the registration, modification of registration conditions, and renewal of registration for devices in the List of reimbursable products and services. Opinions concern cardiovascular and peripheral vascular, neurovascular and neuromodulation, orthopedic, endocrine, ENT, dermatological, and spine-related devices, as well as digital care and medical aids.

Read more